Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
Mangrol, the third ASW-SWC, which has more than 80% indigenous content, was handed over to…
India has come up with its first-ever Soil Texture Map by the National Bureau of…
President Droupadi Murmu will present the National Teachers’ Awards 2026 on 5 September 2026 (Teachers'…
Mobile Phone Manufacturing Scheme (MPMS) of INR 62,500 Crore has been announced by the Centre…
Sophie Adenot is a French engineer, helicopter test pilot, military officer and European Space Agency…
The technology for the development of Submarine-Fired Decoy (SFD) has been handed over to Bharat…